Insider

Labcorp released third-quarter 2026 financial results

Labcorp Holdings Inc. reported financial results for the third quarter ended September 30, 2026. The company invested $255.5 million in acquisitions and paid $58.2 million in dividends.

Verified against 2 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Rows of medical blood collection tubes with colorful caps in a laboratory rack
Photo by Testalize.me on Unsplash
$255.5 million
Acquisition investments
$58.2 million
Dividends paid

Financial results and development.

The company reported performance results for the quarter ended September 30, 2026. During this period, Labcorp invested $255.5 million in acquisitions and paid $58.2 million in dividends.

Third-quarter 2026 expenditures.

Acquisition investments.
$255.5 million
Dividends paid.
$58.2 million
Data from the original sources listed alongside.

Revenue by quarter, $B

3.3Q4 '24*6.5%3.3Q1 '259.7%3.5Q2 '2511.2%3.6Q3 '2511.1%3.5Q4 '25*7.6%3.5Q1 '2610.8%3.7Q2 '2612.1%3.8Q3 '2610.6%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.

Future acquisitions.

The company signed agreements to acquire select assets of BioReference Health, the prenatal health testing business of Myriad Genetics, and Millennium Health. The transactions are subject to regulatory approval and customary closing conditions.

Original sources

  1. 8-K EX-99.1 filing, October 28, 2026October 28, 2026SHA-256 of our archived copy 4058782959f6…
  2. 8-K filing, October 28, 2026October 28, 2026SHA-256 of our archived copy 84bf894bf619…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards